Morgan Stanley 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 10:43 am Purchase |
2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
MORGAN STANLEY MS |
17,629,264 8.600% |
17,629,264 (New Position) |
Filing |